Information on results of RFP – 026746 - PREPARATION AND PRINTING OF LABELS FOR THE IMP PRODUCT IN A PHASE I CLINICAL TRIAL

In connection with co-financing the project "Clinical trial of the first phase (Ia/Ib) of a fusion protein with a dual anticancer mechanism", financed from the State budget by Medical Research Agency (no. 2022/ABM/05/00006-00), acting pursuant to §8 of the co-financing agreement, Adamed Pharma S.A. informs that  the order remains unresolved due to the lack of offers.